AI Article Synopsis

  • Infant sibling studies have significantly advanced research on autism spectrum disorders (ASD), revealing early signs and the disorder's developmental trajectory.
  • Shifting enrollment focus from infancy to conception allows for a deeper investigation into risk factors and biomarkers related to ASD during critical developmental periods.
  • The review emphasizes the enriched-risk pregnancy cohort method for studying infant siblings and highlights the design and implementation of the Early Autism Risk Longitudinal Investigation (EARLI) study.

Article Abstract

Infant sibling studies have been at the vanguard of autism spectrum disorders (ASD) research over the past decade, providing important new knowledge about the earliest emerging signs of ASD and expanding our understanding of the developmental course of this complex disorder. Studies focused on siblings of children with ASD also have unrealized potential for contributing to ASD etiologic research. Moving targeted time of enrollment back from infancy toward conception creates tremendous opportunities for optimally studying risk factors and risk biomarkers during the pre-, peri- and neonatal periods. By doing so, a traditional sibling study, which already incorporates close developmental follow-up of at-risk infants through the third year of life, is essentially reconfigured as an enriched-risk pregnancy cohort study. This review considers the enriched-risk pregnancy cohort approach of studying infant siblings in the context of current thinking on ASD etiologic mechanisms. It then discusses the key features of this approach and provides a description of the design and implementation strategy of one major ASD enriched-risk pregnancy cohort study: the Early Autism Risk Longitudinal Investigation (EARLI).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436647PMC
http://dx.doi.org/10.1186/1866-1955-4-7DOI Listing

Publication Analysis

Top Keywords

enriched-risk pregnancy
12
pregnancy cohort
12
infant siblings
8
autism risk
8
risk factors
8
asd etiologic
8
cohort study
8
asd
6
siblings investigation
4
investigation autism
4

Similar Publications

Prior work has examined associations between cardiometabolic pregnancy complications and autism spectrum disorder (ASD) but not how these complications may relate to social communication traits more broadly. We addressed this question within the Environmental Influences on Child Health Outcomes program, with 6,778 participants from 40 cohorts conducted from 1998-2021 with information on ASD-related traits via the Social Responsiveness Scale. Four metabolic pregnancy complications were examined individually, and combined, in association with Social Responsiveness Scale scores, using crude and adjusted linear regression as well as quantile regression analyses.

View Article and Find Full Text PDF

Pregnancy measures of DNA methylation, an epigenetic mark, may be associated with autism spectrum disorder (ASD) development in children. Few ASD studies have considered prospective designs with DNA methylation measured in multiple tissues and tested overlap with ASD genetic risk loci. To estimate associations between DNA methylation in maternal blood, cord blood, and placenta and later diagnosis of ASD, and to evaluate enrichment of ASD-associated DNA methylation for known ASD-associated genes.

View Article and Find Full Text PDF

Prenatal phthalate exposure measurement: A comparison of metabolites quantified in prenatal maternal urine and newborn's meconium.

Sci Total Environ

November 2021

AJ Drexel Autism Institute, Drexel University, 3020 Market St, Suite 560, Philadelphia, PA 19104, USA; College of Health and Human Development, Pennsylvania State University, 325 HHD Building, University Park, PA 16802, USA.

Phthalates are chemicals suspected to adversely affect fetal neurodevelopment, but quantifying the fetal exposure is challenging. While prenatal phthalate exposure is commonly quantified in maternal urine, the newborn's meconium may better capture cumulative prenatal exposure. Currently, data on phthalates measured in meconium is sparse.

View Article and Find Full Text PDF

We examined maternal prenatal vitamin use or supplemental folic acid intake during month one of pregnancy for association with autism spectrum disorder (ASD) in the Early Autism Risk Longitudinal Investigation, an enriched-risk pregnancy cohort. Total folic acid intake was calculated from monthly prenatal vitamins, multivitamins, and other supplement reports. Clinical assessments through age 3 years classified children as ASD (n = 38) or non-ASD (n = 153).

View Article and Find Full Text PDF
Article Synopsis
  • Linear regression is commonly used to analyze the relationship between chemical exposure and neurodevelopment, but this study explores how these associations vary across different levels of neurodevelopmental outcomes, particularly for those at the extremes.
  • Using quantile regression, researchers assessed the impact of gestational phthalate exposure on Autism Spectrum Disorder (ASD)-related behaviors in children by combining data from two studies, the EARLI Study and the HOME Study, focusing on urine samples from pregnant mothers and caregiver reports of children's behaviors.
  • Findings revealed that in the EARLI Study, most associations were either negative or non-existent; however, in the HOME Study, stronger positive associations between certain phthalate levels and ASD behaviors were found among children with more severe ASD-related
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!